Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery
ConclusionPlasma metabolomic analysis could be used to predict EOC recurrence. While post-operative biomarkers have a predictive advantage over pre-operative biomarkers, combining pre- and post-operative biomarkers showed the best predictive performance and has great potential for predicting recurrent EOC.
Source: Metabolomics - Category: Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Epithelial Cancer | Ovarian Cancer | Ovaries | Study